You are here: Industry Insights > patients

News List

Edge Therapeutics & PDS Biotechnology to Merge contractpharma
November 27, 2018
Edge Therapeutics, Inc. and PDS Biotechnology Corporation announced that their respective boards of directors have approved a definitive merger agreement.
AIVITA Announces Treatment of First Two Patients in Phase 2 Glioblastoma Trial americanpharmaceuticalreview
November 20, 2018
AIVITA Biomedical has dosed the first two patients in its Phase 2 clinical trial in patients with newly diagnosed gliobl
Online Tool Helps Patients With Advance Care Planning drugs
November 14, 2018
Online Tool Helps Patients With Advance Care Planning
AI may help assess brain injury patients biospectrumasia
October 25, 2018
Studies have shown that patients with traumatic brain injury have a higher likelihood of recovery than those with non-traumatic brain injury, and young patients are more likely to have a favourable outcome than older ones.
Cellular Biomedicine Group Enters Into Strategic Licensing and Collaboration Agreement with a Global Leader in CAR-T Cell Therapy for Patients in China pharmafocusasia
September 29, 2018
Cellular Biomedicine Group Inc today announced it has entered into a strategic licensing and collaboration agreement with Novartis to manufacture and supply the CAR-T cell therapy Kymriah® (tisagenlecleucel) in China. Novartis will be the exclusive holder
Alexion's Soliris almost entirely eliminates relapses in rare neuromyelitis optica spectrum disorder pharmafile
September 27, 2018
Alexion has revealed new Phase 3 findings for Soliris (eculizumab), showing the drug met its primary endpoint in the treatment of anti-aquaporin-4 (AQP4)...
Roche to file entrectinib for ROS-1 positive NSCLC pharmatimes
September 27, 2018
Roche is planning to file its investigational cancer drug entrectinib following positive results from early and mid-stage trials with patients...
Sanofi's Dupixent improves symptoms for adolescent atopic dermatitis patients pharmafile
September 20, 2018
Sanofi’s Dupixent (dupilumab) has made a strong showing as a monotherapy at Phase 3 in the treatment of moderate-to-severe atopic dermatitis in patients...
FDA expand REMS education program in effort against opioid crisis pharmafile
September 20, 2018
The US Food and Drug Administration is set to introduce a requirement that all healthcare providers be offered educational training in pain management...
NICE rejects CAR-T therapy Kymriah for DLBCL in adults pharmafile
September 20, 2018
The National Institute for health and Care Excellence (NICE) has rejected Novartis’ CAR-T therapy Kymriah for use in adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).

Previous page 1 2 3 4 5 6 7 8 Next page